WIDAPLIK™, a newly FDA-approved triple combo pill, promises better blood pressure control for adults, including those starting hypertension treatment for the first time.

Reflecting ongoing concerns around drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation (CDSCO) has flagged 130 drug samples as Not ...

Widaplik (previously known as GMRx2) is a combination of three well-established antihypertensive medicines – telmisartan, amlodipine, and indapamide – and heads a pipeline of medicines at ...

Amlodipine Besylate Versus Candesartan Cilexetil in Hypertensive Patients -- Office and Self-Measured Blood Pressure A Randomised, Double-Blind, Comparative, Multicentre Trial ...

WIDAPLIK combines three medications - telmisartan , amlodipine , and indapamide , into one pill, providing the benefits of multiple drugs with proven safety and tolerability .

Is combined renin-angiotensin system inhibition especially effective to improve neuroendocrine blockade in CHF patients?

Warning lists the risk of myocarditis as 8 cases per 1 million who got the 2023-2024 COVID shots ...

Motorsports coverage includes news, highlights, rankings and more spanning NASCAR, Formula 1, NHRA, ARCA, MotoGP, IndyCar and more auto racing circuits.